- EN
Products and services
New EMCDDA Manual
Guidelines for the evaluation of treatment in the field of problem drug use is the title of the recently published third edition in the EMCDDA’s Manuals series. Following on from two earlier manuals on the evaluation of prevention and outreach work, it completes a trilogy of EMCDDA guidelines for evaluating interventions against problem drug use.
Targeted at drug treatment professionals, researchers and officials in social and health authorities, the guidelines provide basic information on the options, elements and procedures available for evaluating drug-related treatment in Europe. It is hoped that they will also help promote a shift in policy towards a more widespread and systematic evaluation of treatment programmes and services in the EU Member States.
Ulrik Solberg and Ambros Uchtenhagen
A cannabis reader: global issues and local experiences
Smoked, eaten, imbibed — or just talked about — the world has an insatiable appetite for cannabis. 1 in 5 European adults have tried it; 13 million Europeans have consumed it in the past month. Nearly 50,000 tonnes of cannabis herb or resin are produced each year. Little wonder, then, that cannabis has become a controversial cultural and commercial phenomenon.
This Spring, the EMCDDA publishes the latest in its edition of scientific monographs: A cannabis reader: global issues and local experiences — Perspectives on cannabis controversies, treatment and regulation in Europe. Published in two volumes totalling over 700 pages, the publication covers the history, pharmacology, trafficking, treatment, consumption and legal status of cannabis. It also illustrates that cannabis is not just a static, unchanging plant, but a dynamic product that is subject to gradual evolution in potency, prevalence, cultivation, legislative and public health concerns. See next edition of Drugnet Europe for more details. EMCDDA monographs in print and downloadable in English
Peter Thomas
Drugs in focus looks at ageing drug users
'Substance use among older adults: a neglected problem' is the topic of the next in the EMCDDA’s policy briefing series to be published in March. 'Substance use is generally associated with young people, but such problems have no age limits', says the briefing. 'Forecasts for the coming years are troubling, and substance use by older adults is likely to become a neglected problem among our neglected citizens'. See next edition of Drugnet Europe for more details. Drugs in focus in print and downloadable in 25 languages
General report of activities 2007
This annual publication presenting the EMCDDA’s achievements under its 2007 work programme will be released on the website in April.
In this issue...
- EMCDDA 'performing well'
- New Scientific Committee
- New E-POD case study on GHB and GBL
- Improving data collection on retail drug prices in Europe
- Exploiting data from hospital and ambulance emergency services
- International conference on drug trafficking in Guinea-Bissau
- Standardising the monitoring of drug-related public expenditure
- UNGASS review gets under way
- New ELDD 'Topic overviews'
- EMCDDA and ESPAD agree cooperation framework
- Technical assistance project with the Western Balkans kicks off
- EU agencies: EMCDDA takes up coordination
Drugnet Europe is also available in downloadable PDF format, for printing or offline browsing.
Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.
Page last updated: Monday, 18 February 2008